Solid retard formulations based on solid dispersions

US10463739B2 · kind B2 · utility

Assignee

• Abb Vie Deutschland Gmbh & Co. KG · DE

Inventors

• Gunther Berndl · Herxheim, DE
• Juergen Weis · Frankfurt am Main, DE
• Dietrich Granzow · Ludwigshafen, DE
• Bernd Liepold · Dossenheim, DE
• Ute Lander · Dannenfels, DE
• Ulrich Westedt · Schriesheim, DE

Key dates

• Filing date: Dec 22, 2011
• Grant date: Nov 5, 2019
• Expiry date: Jan 14, 2033

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K9/2031
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A formulation comprising a melt-processed solid dispersion product comprising an active agent, a pharmaceutically acceptable thermoplastic polymer of N-vinyl lactams, and a pharmaceutically acceptable polyvinyl alcohol-polyalkylene glycol graft copolymer. A method for producing said formulation.